5Niederhuber JE, Brennan MF. Menek HR. The national cancer data base report on pancreatic cancer[J].Cancer. 1995,76:1671 - 1677.
6Song MM,Nio Y,Salo Y,et al. Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas[J].Int J Pancreatol,1996,20:85-93.
7Motojima K.Tsunoda T,Kanematsu T, et al. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten ras oncogene[J ].Ann Surg, 1991.214(6):657 -662.
8Niederhuber J E, Brennan M F, Menck H R. The National Cancer Data Base report on pancreatic canccr[J]. Cancer, 1995,76(9):1671-1677.
9Matter R. de Andrade CRA, DiFAvero GM, et al. Preoperative serum levels of CA-724、CEA、CA- 199, and AFP in patients with gastric cancer. Rev Hosp Clin FAc Med S. Paulo. 2002, 57(3) :89 ～92.
10Steinberg WM, Gelfand R, Anderson KK. Comparison of the sensitivity and specifityof the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.Gastroenterology, 1986,90: 343～348
